A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC)
Conditions: Hepatocellular Carcinoma; Liver Cancer; Cholangiocarcinoma Intervention: Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Research | Science | Urology & Nephrology